BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

331 related articles for article (PubMed ID: 10562548)

  • 1. The downregulation of the pro-apoptotic protein Par-4 is critical for Ras-induced survival and tumor progression.
    Barradas M; Monjas A; Diaz-Meco MT; Serrano M; Moscat J
    EMBO J; 1999 Nov; 18(22):6362-9. PubMed ID: 10562548
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Induction of p202, a modulator of apoptosis, during oncogenic transformation of NIH 3T3 cells by activated H-Ras (Q61L) contributes to cell survival.
    Xin H; Geng Y; Pramanik R; Choubey D
    J Cell Biochem; 2003 Jan; 88(1):191-204. PubMed ID: 12461788
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rit, a non-lipid-modified Ras-related protein, transforms NIH3T3 cells without activating the ERK, JNK, p38 MAPK or PI3K/Akt pathways.
    Rusyn EV; Reynolds ER; Shao H; Grana TM; Chan TO; Andres DA; Cox AD
    Oncogene; 2000 Sep; 19(41):4685-94. PubMed ID: 11032018
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Opposite role of Ras in tumor necrosis factor-alpha-induced cell cycle regulation: competition for Raf kinase.
    Park SJ; Kim YY; Lim JY; Seo GJ; Kim J; Park SI; Park BJ
    Biochem Biophys Res Commun; 2001 Oct; 287(5):1140-7. PubMed ID: 11587542
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regulation of p53 expression by the RAS-MAP kinase pathway.
    Agarwal ML; Ramana CV; Hamilton M; Taylor WR; DePrimo SE; Bean LJ; Agarwal A; Agarwal MK; Wolfman A; Stark GR
    Oncogene; 2001 May; 20(20):2527-36. PubMed ID: 11420662
    [TBL] [Abstract][Full Text] [Related]  

  • 6. SCH 51344 inhibits ras transformation by a novel mechanism.
    Kumar CC; Prorock-Rogers C; Kelly J; Dong Z; Lin JJ; Armstrong L; Kung HF; Weber MJ; Afonso A
    Cancer Res; 1995 Nov; 55(21):5106-17. PubMed ID: 7585559
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activated ras oncogene collaborates with HBx gene of hepatitis B virus to transform cells by suppressing HBx-mediated apoptosis.
    Kim YC; Song KS; Yoon G; Nam MJ; Ryu WS
    Oncogene; 2001 Jan; 20(1):16-23. PubMed ID: 11244501
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Selective activation of Ha-ras(val12) oncogene increases susceptibilityof NIH/3T3 cells to TNF-alpha.
    Chang MY; Won SJ; Yang BC; Jan MS; Liu HS
    Exp Cell Res; 1999 May; 248(2):589-98. PubMed ID: 10222151
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ras downregulation of protein kinase C mRNA in C3H 10T1/2 fibroblasts.
    Fernandes ER; Ashendel CL
    Mol Carcinog; 1996 Sep; 17(1):23-34. PubMed ID: 8876672
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A modest reduction in c-myc expression has minimal effects on cell growth and apoptosis but dramatically reduces susceptibility to Ras and Raf transformation.
    Bazarov AV; Adachi S; Li SF; Mateyak MK; Wei S; Sedivy JM
    Cancer Res; 2001 Feb; 61(3):1178-86. PubMed ID: 11221849
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ras stimulates DNA topoisomerase II alpha through MEK: a link between oncogenic signaling and a therapeutic target.
    Chen G; Templeton D; Suttle DP; Stacey DW
    Oncogene; 1999 Nov; 18(50):7149-60. PubMed ID: 10597316
    [TBL] [Abstract][Full Text] [Related]  

  • 12. DAP kinase activates a p19ARF/p53-mediated apoptotic checkpoint to suppress oncogenic transformation.
    Raveh T; Droguett G; Horwitz MS; DePinho RA; Kimchi A
    Nat Cell Biol; 2001 Jan; 3(1):1-7. PubMed ID: 11146619
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Raf and RhoA cooperate to transform intestinal epithelial cells and induce growth resistance to transforming growth factor beta.
    Du J; Jiang B; Coffey RJ; Barnard J
    Mol Cancer Res; 2004 Apr; 2(4):233-41. PubMed ID: 15140945
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dlk/ZIP kinase-induced apoptosis in human medulloblastoma cells: requirement of the mitochondrial apoptosis pathway.
    Kögel D; Reimertz C; Mech P; Poppe M; Frühwald MC; Engemann H; Scheidtmann KH; Prehn JH
    Br J Cancer; 2001 Nov; 85(11):1801-8. PubMed ID: 11742505
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Essential role of Raf in Ras transformation and deregulation of matrix metalloproteinase expression in ovarian epithelial cells.
    Ulkü AS; Schäfer R; Der CJ
    Mol Cancer Res; 2003 Dec; 1(14):1077-88. PubMed ID: 14707291
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ornithine decarboxylase induction in transformation by H-Ras and RhoA.
    Shantz LM; Pegg AE
    Cancer Res; 1998 Jul; 58(13):2748-53. PubMed ID: 9661886
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Retroviral gene transfer of dominant negative raf-1 mutants suppresses ha-ras-induced transformation and delays tumor formation.
    Heinicke T; Radziwill G; Nawrath M; Rommel C; Pavlovic J; Moelling K
    Cancer Gene Ther; 2000 May; 7(5):697-706. PubMed ID: 10830717
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cooperation between STAT5 and phosphatidylinositol 3-kinase in the IL-3-dependent survival of a bone marrow derived cell line.
    Rosa Santos SC; Dumon S; Mayeux P; Gisselbrecht S; Gouilleux F
    Oncogene; 2000 Feb; 19(9):1164-72. PubMed ID: 10713704
    [TBL] [Abstract][Full Text] [Related]  

  • 19. H-ras and raf-1 cooperate in transformation of NIH3T3 fibroblasts.
    Cuadrado A; Bruder JT; Heidaran MA; App H; Rapp UR; Aaronson SA
    Oncogene; 1993 Sep; 8(9):2443-8. PubMed ID: 8361757
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ectopic expression of Par-4 leads to induction of apoptosis in CNS tumor cell lines.
    Vetterkind S; Boosen M; Scheidtmann KH; Preuss U
    Int J Oncol; 2005 Jan; 26(1):159-67. PubMed ID: 15586236
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.